About Cosmo Pharmaceuticals
Cosmo Pharmaceuticals is a company based in Dublin (Ireland) founded in 1996 by Mauro Ajani.. The company has 321 employees as of December 31, 2024. Cosmo Pharmaceuticals has completed 2 acquisitions, including BioXell and Cassiopea. Cosmo Pharmaceuticals operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, Alcresta and Norgine, among others.
- Headquarter Dublin, Ireland
- Employees 321 as on 31 Dec, 2024
- Founders Mauro Ajani
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cosmo Pharmaceuticals Nv
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cosmo Pharmaceuticals
Cosmo Pharmaceuticals is a publicly listed company on the SIX with ticker symbol COPN in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Cosmo Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2008 | Amount | Post-IPO - Cosmo Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cosmo Pharmaceuticals
Cosmo Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Invision. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Invision is engaged in providing investment and succession solutions for mid-sized companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cosmo Pharmaceuticals
Cosmo Pharmaceuticals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BioXell and Cassiopea. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical-stage pharma company focused on Italian dermatology treatments.
|
2009 | ||||
|
Italian, clinical stage biopharma developing small molecule and antibody therapeutics for chronic inflammatory and autoimmune diseases
|
2002 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cosmo Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cosmo Pharmaceuticals Comparisons
Competitors of Cosmo Pharmaceuticals
Cosmo Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, Alcresta and Norgine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| domain | founded_year | HQ Location |
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cosmo Pharmaceuticals
Frequently Asked Questions about Cosmo Pharmaceuticals
When was Cosmo Pharmaceuticals founded?
Cosmo Pharmaceuticals was founded in 1996 and raised its 1st funding round 12 years after it was founded.
Where is Cosmo Pharmaceuticals located?
Cosmo Pharmaceuticals is headquartered in Dublin, Ireland.
How many employees does Cosmo Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Cosmo Pharmaceuticals is 321.
What is the annual revenue of Cosmo Pharmaceuticals?
Annual revenue of Cosmo Pharmaceuticals is $280.52M as on Dec 31, 2024.
What does Cosmo Pharmaceuticals do?
Cosmo Pharmaceuticals was founded in 1996 in Dublin, Ireland, within the pharmaceuticals sector. Therapeutics targeting gastrointestinal diseases are developed, including Aemcolo for inflammatory bowel conditions, Byfavo for sedation in colonoscopy procedures, MethyleneBlue MMX for lesion detection during colonoscopies, and CB-03-10 for solid tumors. Additionally, GI Genius AI-enhanced software is provided to support endoscopy processes.
Who are the top competitors of Cosmo Pharmaceuticals?
Cosmo Pharmaceuticals's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Is Cosmo Pharmaceuticals publicly traded?
Yes, Cosmo Pharmaceuticals is publicly traded on SIX under the ticker symbol COPN.
How many acquisitions has Cosmo Pharmaceuticals made?
Who are Cosmo Pharmaceuticals's investors?
Cosmo Pharmaceuticals has 1 investor. Key investors include Invision.
What is Cosmo Pharmaceuticals's ticker symbol?
The ticker symbol of Cosmo Pharmaceuticals is COPN on SIX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.